Feature | April 08, 2011

Egyptian Mummies Show Earliest Cases of Coronary Disease on CT

Proof of heart disease dating back 3,550 years prompts researchers to question whether there is a missing link in understanding this “modern” condition

Calcification in in the aortic bifurcation of an Egyptian mummy.

Annular valve stenosis in the heart of an Egyptian mummy.

Carotid stenosis in an Egyptian mummy.

Coronary stenosis in the heart of an Egyptian mummy.

Peripheral artery disease in an Egyptian mummy.

A U.S.-Egyptian research team has uncovered the earliest documented case of coronary atherosclerosis in a princess who died in her early 40s and lived between 1580 and 1550 B.C. Of the other mummies studied – a sampling of the elite in ancient Egypt – almost half showed evidence of atherosclerosis in one or more of their arteries, calling into question our perception of atherosclerosis as a modern disease, according to research presented this week at the American College of Cardiology (ACC) Scientific Session in New Orleans.

While atherosclerosis has been observed before in ancient Egyptians, this study found it to be more prevalent than previously thought. The interdisciplinary team performed whole body computerized tomography (CT) scans on 52 ancient Egyptian mummies to determine if atherosclerosis was present. Of the 44 with identifiable arteries or hearts, nearly half (45 percent) had calcifications either in the wall of an artery or along the course of an artery that are diagnostic of or highly suggestive of atherosclerosis. “Commonly, we think of coronary artery or heart disease as a consequence of modern lifestyles, mainly because it has increased in developing countries as they become more westernized,” said Gregory S. Thomas, M.D., MPH, clinical professor and director of nuclear cardiology education, University of California, Irvine and the study’s co-principal investigator.

“These data point to a missing link in our understanding of heart disease, and we may not be so different from our ancient ancestors.” Most of the atherosclerosis was found in the large arteries of the body, including the aorta in the abdomen. However, key smaller arteries were also involved. About 7 percent of the mummies had obstructions in the heart arteries, and 14 percent had blockages in the arteries to the brain, the carotid arteries, which is a leading cause of stroke in the present day. Researchers also found that, similar to now, advancing age was highly predictive of the presence and severity of atherosclerosis.

Thomas explains that the calcific atherosclerosis seen with CT scanning looks just like the atherosclerosis of today and appears in the same locations. While researchers could not determine the exact cause of death in these mummies, symptoms consistent with cardiac chest pain had been described in ancient Egyptian scrolls. In order to understand the lifestyles of ancient Egypt’s elite, the team of researchers worked with Egyptologists to review risk factors that might affect the health of the heart and arteries.

“We suspect, but do not know, that meat, which was certainly leaner at that time, was a smaller part of their diet than ours today,” Thomas said. “We know that Egyptians had an overall better diet, did not smoke cigarettes and were more active – yet they still have the same disease we have. This discovery points to the fact that we don’t understand atherosclerosis and heart disease as well as we think we do.”

Although the findings require further study, Thomas and his co-principal investigator, Adel Allam, M.D., of Al Azhar University, Cairo, Egypt believe these data suggest that genetic factors resulting in atherosclerosis are more important than previously thought. They caution, however, that the genetic factors that may predispose us to the disease are even more compelling reasons to carefully manage risk factors that we have some control over, if not to prevent atherosclerosis, to minimize its impact.

“Recent studies have shown that by not smoking, having a lower blood pressure and a lower cholesterol level, calcification of our arteries is delayed,” said Allam. “On the other hand, from what we can tell from this study, humans are predisposed to atherosclerosis, so it behooves us to take the proper measures necessary to delay it as long as we can.”

Mummies were preserved by going through a 70-day sterilization and dehydration process using natron, a mixture of sodium carbonate, sodium bicarbonate, sodium sulfate and sodium chloride, which allows the bodies to be recognizable and studied 3,500 or more years later. The study was funded by the National Bank of Egypt, Siemens and the St. Luke’s Hospital Foundation. Cardiology co-investigators include: doctors. Randall Thompson of the St. Luke’s Mid-America Heart Institute, Kansas City, Mo.; Sam Wann of the Wisconsin Heart Hospital, Milwaukee, Wis.; and Michael I. Miyamoto of the Mission Internal Medical Group, Mission Viejo, Calif.

This study is published in print and online in the JACC: Cardiovascular Imaging April 2011 edition.

Related Content

Apollo Enterprise Imaging, DiACardio, Enterprise Patient Multimedia Manager, EPMM, LVivo Toolbox
Technology | Clinical Decision Support| January 19, 2017
January 19, 2017 — Apollo Enterprise Imaging Corp.
TAVR, medical guidelines, ACC/AHA, optimization, transcatheter aortic valve replacement
News | Heart Valve Technology| January 18, 2017
The American College of Cardiology recently released new guidance for clinicians and hospitals to use in assessing...
Medtronic, CoreValve Evolut R 34 mm valve, TAVI, CE Mark, European launch
News | Heart Valve Technology| January 17, 2017
Medtronic plc announced the CE (Conformité Européenne) mark and European launch of the CoreValve Evolut R 34 mm valve...
MD Buyline, James Laskaris, four medical technology innovations, very near future
Feature | Cardiac Imaging| January 17, 2017
James Laskaris, emerging technology analyst at MD Buyline, recently offered his perspective on new medical technology...
Synergy stent, abluminal polymer DES, bioresorbable polymer DES, bioresorbable polymer metallic stent

The Synergy stent is the first FDA cleared drug-eluting stent to use a bioresorbable polymer drug carrier. When the polymer dissolves after about four months, the devices become a bare metal stent. The technology is supposed to reduce the rate of late stent thrombosis due to vessel inflammation caused by durable polymers.

Feature | Stents Bioresorbable| January 17, 2017 | Dave Fornell
One of the big advancements in drug-eluting stent (DES) technology has been the development of bioresorbable polymers
St. Jude Medical, Amplatzer Amulet LAA Occluder, observational study, TCT 2016
News | Left Atrial Appendage (LAA) Occluders| November 03, 2016
St. Jude Medical Inc. presented favorable results from the largest observational study to date of the company’s...
Medtronic, CoreValve Evolut R TAVR system, U.S. IDE Study, TCT 2016
News | Heart Valve Technology| November 03, 2016
Medtronic plc unveiled new clinical data showing that patients treated with the self-expanding CoreValve Evolut R...
congenital heart patients, cardiac cath lab, anesthesia sedation practices, joint document, SCAI, SPA, CCAS
News | Congenital Heart| November 03, 2016
The Society for Cardiovascular Angiography and Interventions (SCAI), the Society for Pediatric Anesthesia (SPA) and the...
open-heart surgery, PCI, percutaneous coronary intervention, NOBLE trial, left main coronary artery disease, LMCAD, TCT 2016
News | Cardiovascular Surgery| November 03, 2016
Coronary artery bypass (CABG) surgery is the standard treatment for revascularization in patients with left main...
SENTINEL trial, transcatheter embolic protection, TCEP, TAVR, stroke, TCT 2016
News | Embolic Protection Devices| November 03, 2016
An international study has found that transcatheter cerebral embolic protection (TCEP) is safe, provides effective...
Overlay Init